| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYB5R3 mRNA | CTD | PMID:17108234 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731731 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYB5R3 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYB5R3 mRNA | CTD | PMID:21215274 PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731731 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYB5R3 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557763 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYB5R3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYB5R3 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1557763 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYB5R3 mRNA | CTD | PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYB5R3 protein | CTD | PMID:16548065 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CYB5R3 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CYB5R3 mRNA | CTD | PMID:21346803 |
| 2-nitrofluorene | decreases expression | EXP | | 6480464 | 2-nitrofluorene results in decreased expression of CYB5R3 mRNA | CTD | PMID:14600272 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of CYB5R3 mRNA | CTD | PMID:19162173 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CYB5R3 mRNA | CTD | PMID:14600272 |
| 7,12-dimethyltetraphene | affects expression | ISO | RGD:1557763 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene affects the expression of CYB5R3 mRNA | CTD | PMID:21785161 |
| aflatoxin B1 | decreases expression | ISO | RGD:1557763 | 6480464 | Aflatoxin B1 results in decreased expression of CYB5R3 mRNA | CTD | PMID:19770486 |
| alpha-hexachlorocyclohexane | increases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in increased expression of CYB5R3 mRNA | CTD | PMID:17785943 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYB5R3 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1557763 | 6480464 | Benzo(a)pyrene results in decreased expression of CYB5R3 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | affects expression | ISO | RGD:1557763 | 6480464 | Benzo(a)pyrene affects the expression of CYB5R3 mRNA | CTD | PMID:22342234 |
| bezafibrate | affects expression | EXP | | 6480464 | Bezafibrate affects the expression of CYB5R3 mRNA | CTD | PMID:17719200 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CYB5R3 mRNA | CTD | PMID:19167457 |
| choline | multiple interactions | ISO | RGD:1557763 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYB5R3 mRNA | CTD | PMID:20938992 |
| ciglitazone | multiple interactions | ISO | RGD:731731 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYB5R3 mRNA | CTD | PMID:16197558 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CYB5R3 mRNA | CTD | PMID:18172885 |
| cisplatin | increases expression | ISO | RGD:1557763 | 6480464 | Cisplatin results in increased expression of CYB5R3 mRNA | CTD | PMID:21151649 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 PMID:12851107 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYB5R3 mRNA | CTD | PMID:12851107 PMID:17522070 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of CYB5R3 mRNA | CTD | PMID:17602206 |
| copper atom | affects binding | ISO | RGD:731731 | 6480464 | CYB5R3 protein binds to Copper | CTD | PMID:15359738 |
| copper(0) | affects binding | ISO | RGD:731731 | 6480464 | CYB5R3 protein binds to Copper | CTD | PMID:15359738 |
| copper(2+) sulfate | decreases expression | ISO | RGD:731731 | 6480464 | Copper Sulfate results in decreased expression of CYB5R3 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:731731 | 6480464 | Cyclosporine results in decreased expression of CYB5R3 mRNA | CTD | PMID:20106945 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| diarsenic trioxide | increases expression | ISO | RGD:731731 | 6480464 | arsenic trioxide results in increased expression of CYB5R3 mRNA | CTD | PMID:15725085 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CYB5R3 mRNA | CTD | PMID:21266533 |
| erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| folic acid | multiple interactions | ISO | RGD:1557763 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYB5R3 mRNA | CTD | PMID:20938992 |
| hydralazine | multiple interactions | ISO | RGD:731731 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R3 mRNA | CTD | PMID:17183730 |
| hydroxylamine | increases reduction | ISO | RGD:731731 | 6480464 | CYB5R3 protein results in increased reduction of Hydroxylamine | CTD | PMID:21447608 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CYB5R3 mRNA | CTD | PMID:18299717 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of CYB5R3 mRNA | CTD | PMID:20080153 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA; more ... | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:1557763 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYB5R3 mRNA | CTD | PMID:20938992 |
| methylmercury chloride | decreases expression | ISO | RGD:1557763 | 6480464 | methylmercuric chloride results in decreased expression of CYB5R3 mRNA | CTD | PMID:19465457 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CYB5R3 mRNA | CTD | PMID:14600272 |
| NAD zwitterion | affects binding | ISO | RGD:731731 | 6480464 | CYB5R3 protein binds to NAD | CTD | PMID:16469290 |
| NAD(+) | affects binding | ISO | RGD:731731 | 6480464 | CYB5R3 protein binds to NAD | CTD | PMID:16469290 |
| ochratoxin A | decreases expression | ISO | RGD:731731 | 6480464 | ochratoxin A results in decreased expression of CYB5R3 mRNA | CTD | PMID:19287073 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1557763 | 6480464 | perfluorooctanoic acid results in decreased expression of CYB5R3 mRNA | CTD | PMID:20118188 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CYB5R3 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1557763 | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of CYB5R3 mRNA] | CTD | PMID:20118188 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYB5R3 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:1557763 | 6480464 | Phenobarbital affects the expression of CYB5R3 mRNA | CTD | PMID:23091169 |
| phlorizin | decreases expression | ISO | RGD:1557763 | 6480464 | Phlorhizin results in decreased expression of CYB5R3 mRNA | CTD | PMID:22538082 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYB5R3 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of CYB5R3 mRNA | CTD | PMID:19162173 |
| quinidine | decreases expression | EXP | | 6480464 | Quinidine results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of CYB5R3 mRNA | CTD | PMID:17522070 |
| valproic acid | multiple interactions | ISO | RGD:731731 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R3 mRNA | CTD | PMID:17183730 |
| valproic acid | increases expression | ISO | RGD:1557763 | 6480464 | Valproic Acid results in increased expression of CYB5R3 mRNA | CTD | PMID:21427059 |
| zinc atom | affects expression | ISO | RGD:731731 | 6480464 | Zinc affects the expression of CYB5R3 mRNA | CTD | PMID:16979875 |
| zinc(0) | affects expression | ISO | RGD:731731 | 6480464 | Zinc affects the expression of CYB5R3 mRNA | CTD | PMID:16979875 |
| zoledronic acid | increases expression | ISO | RGD:731731 | 6480464 | zoledronic acid results in increased expression of CYB5R3 mRNA | CTD | PMID:20977926 |